Form 4: Jazz Pharmaceuticals Executive Patricia Carr Reports Stock Sale
SEC Form 4
Patricia Carr, SVP and Chief Accounting Officer of Jazz Pharmaceuticals, reported the sale of 163 ordinary shares on June 7, 2024.
Summary
- Patricia Carr, a Senior Vice President and Chief Accounting Officer at Jazz Pharmaceuticals plc, reported a transaction involving the company's ordinary shares.
- On June 7, 2024, Carr disposed of 163 ordinary shares at a price of $108.825 per share.
- Following the transaction, Carr directly owns 6,596 ordinary shares.
- Additionally, 163 ordinary shares were acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: This is a neutral report on an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | 163 ordinary shares were acquired under a Section 423 Employee Stock Purchase Plan. |
| 06/07/2024 | Patricia Carr sold 163 ordinary shares at $108.825 per share. |
| 06/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.